Clinical Trial: A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia

U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06841731) titled 'A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia' on Feb. 19.

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of HRS -8427 in patients with HABP/VABP.

Study Start Date: March, 2025

Study Type: INTERVENTIONAL

Condition: Hospital-acquired Bacterial Pneumonia (HABP) Ventilator-associated Bacterial Pneumonia (VABP)

Intervention: DRUG: HRS-8427

HRS-8427 for injection.

DRUG: Meropenem

Meropenem for injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....